Adageneis A Globalclinical Stageimmunotherapy Company Listed On Nasdaqdedicated To Advancing Antibody Based Cancer Treatmentsthecompany Focuses On Innovativeapproaches To Immunotherapyaiming To Meet Unmet Patient Needs Through Its Advanced Technologies And Strategic Collaborations Central To Adagenes Work Is Its Dynamic Precision Librarydplplatformwhich Includes Threekey Technologiesneobodya C For Novel Antibody Discoverysafebody For Enhancing Safety And Targeting Specific Tumorsand Powerbodya C To Increaseantibody Potencythelead Clinical Programadg126Muzastotug Is A Masked Anti Ctla 4 Safebody Antibody Currently In Phase1B 2 Studies For Treating Metastatic Microsatellitestablecolorectal Cancer In Combination With Anti Pd 1 Therapy Adagenecombines Computational Biology And Artificial Intelligencein Its Antibody Design Process And Has Formed Strategic Partnerships With Global Organizations To Enhancethesafety And Efficacy Of Its Therapiesthecompany Is Committed To Transparency And Regularly Shares Updates On Its Financial Performanceand Clinical Advancements
